Navigation Links
ISPE End-to-End Supply Chain Conference - Stepping up Pharmaceutical Operations
Date:5/1/2013

Brussels, Belgium (PRWEB) May 02, 2013

ISPE announced today that it will hold a conference on key challenges and opportunities in the pharmaceutical supply chain in Prague on 13-14 June 2013. This two-day event will cover critical-to-success factors in pharmaceutical supply chain management in investigational products and the commercial supply chain. Topics covered during the conference will include investigational product management / logistics, the commercial supply chain integrity and cargo risks. Special focus will be given to the EU GDP and GCP legislation and the Falsified Medicines Directive.

Jim McKiernan, CEO, McKiernan Associates, conference chair said, “The industry has made tremendous strides forward in the past decade to improve its supply chain efficiency. However, compared with other sectors, pharma still has a long way to go to achieve truly world-class performance. This conference will allow attendees to hear examples of best practice and gain insights on moving their business forward, as presented by leading practitioners and regulators.”

Esther Sadler-Williams, Senior Director, Catalent Pharma solutions and conference co-chair added, “The conference is organised by industry experts for experts and includes separate tracks specific to IP and supply chain. We will be covering key topics that explore the needs of our ultimate customer – the patient.”

The conference will provide a unique opportunity for supply chain and production plant managers, clinical supply professionals, CROs, CMOs, anti-counterfeiting officers and tech transfer specialists to be updated on the latest technological and regulatory developments in pharmaceutical supply chain operations. In total, more than 30 industry and regulatory speakers from organizations such as MHRA, NHS Scotland, Napp, Boehringer Ingelheim and Cemafroid, will share their knowledge and experience.

For more information on this conference, including detailed agendas and registration information, visit http://www.ISPE.org/2013-Supply-Chain-EU-Conference.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit http://www.ISPE.org for more information.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10682241.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference
2. Michigan's Exotic Automation & Supply Celebrates 50th Anniversary
3. New Webinar on Sensor-based Logistics for Life Science Supply Chains, Hosted by Xtalks
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. EtQ to Host Life Science Summit on the World of Quality and Global Supply Chain
6. Michigan’s Exotic Automation & Supply to Exhibit at the 2013 Work Truck Show & Green Truck Summit
7. Reliable electric power supply for the energy turn-around
8. Verify Brand Enhances VB Enterprise Platform for Greater Supply Chain Security Across Industries
9. High Voltage Power Supply Manufacturer Holds Annual Food Drive to Fight Local Hunger
10. WHEATON® Acquires Chromatography Vial Supply Company, MicroLiter
11. Ryan Herco Flow Solutions Acquires Expert Piping Supply, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):